Emerging insights from metabolomic-based studies of major depression disorder (MDD) are
mainly related to biochemical processes such as energy or oxidative stress, in addition to …

There has been a renewed interest in the potential use of psychedelics for the treatment of
psychiatric conditions. Nevertheless, little is known about the mechanism of action and …

Ethnopharmacology relevance Ayahuasca is a tea produced through decoction of
Amazonian plants. It has been used for centuries by indigenous people of South America …

Alzheimer's disease (AD) is an aging-related neurodegenerative disease, leading to the
progressive loss of memory and other cognitive functions. As there is still no cure for AD, the …

Introduction Major depressive disorder (MDD) is a common mental disease, associated with
a debilitating condition and high prevalence. Although the underlying mechanism of MDD …

Metabolomics can capture global changes and the overall physiological status in
biochemical networks and pathways in order to elucidate sites of perturbations. High …

Depressive disorder is a kind of emotional disorder that is mainly manifested with
spontaneous and persistent low mood. Its etiology is complex and still not fully understood …

Major depressive disorder (MDD) is a highly prevalent, debilitating mental illness of
importance for global health. However, its molecular pathophysiology remains poorly …

Alzheimer's disease (AD) is one of the most common progressive neurodegenerative
diseases, accompanied by global alterations in metabolic profiles. In the past 10 years, over …

Background Depression is a major cause of suicide and mortality worldwide. This study
aims to conduct a systematic review to identify metabolic biomarkers and pathways for major …